We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editorial |

Warfarin After Bioprosthetic Aortic Valve Implantation

Shamir R. Mehta, MD, MSc; Jeffrey I. Weitz, MD
JAMA. 2012;308(20):2147-2148. doi:10.1001/jama.2012.91476.
Text Size: A A A
Published online


In North America, approximately 170 000 patients undergo aortic valve replacement annually, and the majority of these patients receive a bioprosthetic, rather than a mechanical, prosthesis.1 Bioprosthetic valves are more commonly used because many of these patients are elderly and frail and have comorbid conditions that render them at increased risk of bleeding with the prolonged anticoagulation therapy that would be required with implantation of a mechanical valve. A 3-month course of warfarin with or without concomitant aspirin is frequently administered after implantation of a bioprosthetic valve, because observational studies suggest that there is a risk of thromboembolism until the valve support structures are endothelialized.2,3 Although the rates of thromboembolic events among patients given warfarin or the combination of warfarin plus aspirin after bioprosthetic aortic valve implantation appear to be lower than the event rates among patients given aspirin alone, warfarin treatment is associated with more bleeding.4 With the limited evidence to date based primarily on observational studies, the trade-off between reduced thromboembolic events with warfarin and increased bleeding remains uncertain.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

5 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles

Users' Guides to the Medical Literature
Assessing the Strength of Recommendations: The GRADE Approach

Users' Guides to the Medical Literature
Are the Results Valid?